Infectious Diseases in Obstetrics and Gynecology

Infectious Diseases in Obstetrics and Gynecology / 2002 / Article

Open Access

Volume 10 |Article ID 645476 |

Mara J. Dinsmoor, Scott T. Forrest, "Lack of an Effect of Protease Inhibitor Use on Glucose Tolerance During Pregnancy", Infectious Diseases in Obstetrics and Gynecology, vol. 10, Article ID 645476, 5 pages, 2002.

Lack of an Effect of Protease Inhibitor Use on Glucose Tolerance During Pregnancy

Received20 Jun 2002
Accepted20 Nov 2002


Objective: We hypothesized that HIV-positivewomen on protease inhibitors (PIs) would be more likely to have an elevated glucola test result than those not on PIs.Methods: We reviewed our database of all HIV-positive pregnant women seen at our hospital. Serum glucose was measured 1 hour following a 50-g glucola load, at approximately 26–28 weeks of gestation. Statistical analysis was performed using Student's t-test, Fisher's exact test, and the Mann–Whitney rank sum test.Results: Forty-one HIV-infected pregnant women with glucola testing were seen between January 1, 1997 and March 1, 2000. Fourteen patients were on PIs at the time of glucola. One patient in each group had an abnormal glucola test result (glucose ≥140 mg/dl); both had normal 3-hour glucose tolerance tests. The glucola test results were similar between the PI-exposed and unexposed, with a mean difference of 5.8 mg/dl (95% confidence interval 9.2–20.8 mg/dl). Two neonates (both exposed to PI) had hypoglycemia (glucose < 40 mg/dl).Conclusions: The use of PIs does not significantly increase the risk of an elevated glucola result, nor is the mean glucola result increased in the women on PIs. The finding of hypoglycemia in neonates exposed to PIs merits further investigation.

Copyright © 2002 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.